Dr. Neha Mehta-shah, M.D.
Claim this profileWashington University School of Medicine
About Neha Mehta-shah, M.D.
Education:
- MD from Feinberg School of Medicine, Northwestern University, Chicago, IL (2005-2009).
- Masters of Science in Clinical Investigation (MSCI) from Washington University in St. Louis, MO (2016-2019).
- BA in Psychology (Cum Laude) from Northwestern University, Evanston, IL (2002-2005).
Experience:
- Assistant Professor of Medicine at Washington University in St. Louis, specializing in peripheral and cutaneous T-cell lymphomas.
- Fellow in Hematology/Oncology at Memorial Sloan Kettering Cancer Center, New York, NY (2013-2016).
- Chief Medical Resident at Memorial Sloan Kettering Cancer Center, New York, NY (2012-2013).
- Resident in Internal Medicine at New York Presbyterian-Weill Cornell Medical Center, New York, NY (2009-2012).
Area of expertise
Lymphoma
Neha Mehta-shah, M.D. has run 7 trials for Lymphoma. Some of their research focus areas include:
Sezary Syndrome
Neha Mehta-shah, M.D. has run 5 trials for Sezary Syndrome. Some of their research focus areas include:
Affiliated Hospitals
Washington University School Of Medicine
Siteman Cancer Center At West County Hospital
Clinical Trials Neha Mehta-shah, M.D. is currently running
Lenalidomide + Nivolumab
for Lymphoma
This trial tests a combination of drugs to treat a rare brain cancer. The treatment aims to starve the tumor, boost the immune system, and stop cancer cells from growing. It targets patients with primary CNS lymphoma who may not respond well to standard treatments.
Recruiting
1 award
Phase 1
19 criteria
Mosunetuzumab
for Aggressive B-Cell Lymphoma
This phase 1 pilot study examines the feasibility and safety of mosunetuzumab after autologous stem cell transplant for patients with aggressive B cell lymphomas. Mosunetuzumab is an antibody that has been engineered to attach to two target cells in the immune system: T cells that normally perform tasks like killing virus-infected cells, and cancerous B cells. Mosunetuzumab has been designed to direct these T cells to kill the cancerous B cells instead.
Recruiting
2 awards
Phase 1
More about Neha Mehta-shah, M.D.
Clinical Trial Related
4 years of experience running clinical trials · Led 19 trials as a Principal Investigator · 5 Active Clinical Trials
Treatments Neha Mehta-shah, M.D. has experience with
- Nivolumab
- Rituximab
- Duvelisib
- Mosunetuzumab
- Acalabrutinib
- Durvalumab
Breakdown of trials Neha Mehta-shah, M.D. has run
Lymphoma
Sezary Syndrome
Non-Hodgkin's Lymphoma
Mycosis Fungoides/Sezary Syndrome
Cutaneous T-Cell Lymphoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Neha Mehta-shah, M.D. specialize in?
Neha Mehta-shah, M.D. focuses on Lymphoma and Sezary Syndrome. In particular, much of their work with Lymphoma has involved Stage IV patients, or patients who are CD7 positive.
Is Neha Mehta-shah, M.D. currently recruiting for clinical trials?
Yes, Neha Mehta-shah, M.D. is currently recruiting for 5 clinical trials in Saint Louis Missouri. If you're interested in participating, you should apply.
Are there any treatments that Neha Mehta-shah, M.D. has studied deeply?
Yes, Neha Mehta-shah, M.D. has studied treatments such as Nivolumab, Rituximab, Duvelisib.
What is the best way to schedule an appointment with Neha Mehta-shah, M.D.?
Apply for one of the trials that Neha Mehta-shah, M.D. is conducting.
What is the office address of Neha Mehta-shah, M.D.?
The office of Neha Mehta-shah, M.D. is located at: Washington University School of Medicine, Saint Louis, Missouri 63110 United States. This is the address for their practice at the Washington University School of Medicine.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.